GD2-specific CAR T cell therapies for pediatric solid cancers

被引：0
|
作者：
Rossig, Claudia
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 17期
关键词：
D O I：
10.1158/1538-7445.PEDIATRIC24-IA015
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IA015
引用
收藏
页数：2
相关论文
共 50 条
  • [41] eNovel GD2-specific chimeric antigen receptor-modified T cells targeting osteosarcoma
    Chulanetra, Monrat
    Sayour, Elias
    Eldjerou, Lamis
    Lagmay, Joanne
    Milner, Rowan
    Slayton, William
    Chang, Lung-Ji
    CANCER RESEARCH, 2015, 75
  • [42] Immune determinants of CAR-T expansion in solid tumor patients receiving GD2 CAR-T cell therapy
    Murty, Tara
    Kaczanowska, Sabina
    Alimadadi, Ahmad
    Contreras, Cristina
    Duault, Caroline
    Balasubrahmanyan, Priyanka
    Reynolds, Warren
    Gutierrez, Norma
    Baskar, Reema
    Wu, Catherine
    Michor, Franziska
    Altreuter, Jennifer
    Liu, Yang
    Jhaveri, Aashna
    Duong, Vandon
    Anbunathan, Hima
    Moravec, Radim
    Hong, Joyce
    Biswas, Roshni
    Van Nostrand, Stephen
    Lindsay, James
    Pichavant, Mina
    Sotillo, Elena
    Sahaf, Bita
    Bendall, Sean
    Maecker, Holden
    Highfill, Steven
    Stroncek, David
    Merchant, Melinda
    Glod, John
    Hedrick, Catherine
    Mackall, Crystal
    Ramakrishna, Sneha
    Kaplan, Rosandra
    CANCER RESEARCH, 2023, 83 (07)
  • [43] Safety and antitumor activity of GD2-Specific 4SCAR-T cells in patients with glioblastoma
    Zhuohao Liu
    Jiayi Zhou
    Xinzhi Yang
    Yuchen Liu
    Chang Zou
    Wen Lv
    Cheng Chen
    Kenneth King-yip Cheng
    Tao Chen
    Lung-Ji Chang
    Dinglan Wu
    Jie Mao
    Molecular Cancer, 22
  • [44] Design of bispecific adapters for universal CAR T cell therapies of solid tumors
    Zheng, Suilan
    Huang, Bo
    Singh, Yashapal
    Chu, Haiyan
    Bowroju, Suresh K.
    Bari, Md Sazzadul
    Srinivasarao, Madduri
    Kasireddy, Sudarsan R.
    Mukkamala, Ramesh
    Beitz, Laurie
    Ryu, Byoung
    Scharenberg, Andrew M.
    Jensen, Michael
    Low, Philip S.
    CANCER RESEARCH, 2023, 83 (07)
  • [45] A long way to the battlefront: CAR T cell therapy against solid cancers
    Wang, Zhicai
    Chen, Wei
    Zhang, Xing
    Cai, Zhiming
    Huang, Weiren
    JOURNAL OF CANCER, 2019, 10 (14): : 3112 - 3123
  • [46] Involvement of Actin Filaments in the Cytotoxic Effect of GD2-Specific Antibodies
    I. I. Doronin
    I. V. Kholodenko
    A. A. Zubareva
    K. N. Yarygin
    S. M. Deev
    R. V. Kholodenko
    Bulletin of Experimental Biology and Medicine, 2019, 166 : 541 - 547
  • [47] An Automated Manufacturing Solution for Patient Specific CAR-T Cell Therapies
    O'Connor, Joseph William
    Dutta, Debargh
    Daita, Kalyani
    Abraham, Eytan
    Shi, Yaling
    MOLECULAR THERAPY, 2019, 27 (04) : 88 - 88
  • [48] Translational immunoPET imaging using a radiolabeled GD2-specific antibody in neuroblastoma
    Schmitt, Julia
    Schwenck, Johannes
    Maurer, Andreas
    Przybille, Mirko
    Sonanini, Dominik
    Reischl, Gerald
    Wehrmueller, Joeri E.
    Quintanilla-Martinez, Leticia
    Gillies, Stephen D.
    Krueger, Marcel A.
    Schaefer, Juergen F.
    la Fougere, Christian
    Handgretinger, Rupert
    Pichler, Bernd J.
    THERANOSTICS, 2022, 12 (12): : 5615 - 5630
  • [49] GD2-specific CAR T Cells Undergo Potent Activation and Deletion Following Antigen Encounter but can be Protected From Activation-induced Cell Death by PD-1 Blockade
    Gargett, Tessa
    Yu, Wenbo
    Dotti, Gianpietro
    Yvon, Eric S.
    Christo, Susan N.
    Hayball, John D.
    Lewis, Ian D.
    Brenner, Malcolm K.
    Brown, Michael P.
    MOLECULAR THERAPY, 2016, 24 (06) : 1135 - 1149
  • [50] Logic-gated and contextual control of immunotherapy for solid tumors: contrasting multi-specific T cell engagers and CAR-T cell therapies
    Nolan-Stevaux, Olivier
    Smith, Richard
    FRONTIERS IN IMMUNOLOGY, 2024, 15
12345